Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-11-18

FDA Approved: FLUPHENAZINE HYDROCHLORIDE — Original Application (Camber Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved Camber Pharmaceuticals' generic fluphenazine hydrochloride under an ANDA, expanding access to this antipsychotic used to treat schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Fluphenazine hydrochloride (Fluphenazine hydrochloride)

Snippet

ORIG AP for FLUPHENAZINE HYDROCHLORIDE (FLUPHENAZINE HYDROCHLORIDE)